You May be Entitled to Significant Compensation Talc ovarian cancer risk. Johnson & Johnson powders were proven to contain asbestos (a cancer causing agent) and the company failed to notify users of the cancer risk. $2 BILLION has already been awarded to claims. Free To File! No Fees Unless A Settlement Is Awarded!

J&J’s proposed talc settlement will pay the sum of $400 million US state AGs. Talc Ovarian Cancer Risk .

Johnson & Johnson (JNJ.N) has put aside $400 million to settle U.S. state consumer protection actions as part of its wider $8.9 billion effort to settle allegations that its Baby Powder and other talc products cause cancer. Talc ovarian cancer risk.

J&J subsidiaries LTL Management filed a bankruptcy plan in New Jersey late on Monday that outlines how the firm intends to pay for different types of cancer victims as part of an arrangement for bankruptcy. Talc ovarian cancer risk. J&J has claimed that its Talc products are safe, and do not cause cancer. It is attempting for the second time to end more than 38,000 lawsuits in bankruptcy and prevent new cases from being filed in the future.
LTL’s bankruptcy plan would pay $400 million to an additional trust to settle claims brought from state attorney generals alleging that J&J violated state unfair business practices as well as consumer protection laws through misleading consumers about the safety of its talc products.

Several states had begun consumer protection measures against J&J before LTL’s first bankruptcy filing prevented those investigations from taking place in 2021. Talc ovarian cancer risk. New Mexico and Mississippi had already filed suit in the past against Johnson & Johnson before then as well as the states of Arizona, Maryland, North Carolina, Texas and Washington had issued civil investigative demands or subpoenas according to court filings.

New Mexico and Mississippi have filed a petition to end LTL’s bankruptcy, joining cancer victims and their counterparts from the U.S. Justice Department’s watchdog on bankruptcy, who have argued that a successful company like J&J cannot benefit from bankruptcy protections designed for those struggling with debt.
The company’s initial attempt to resolve the lawsuits in bankruptcy was dismissed after similar arguments. In the end, a U.S. appeals court decided the LTL did not have “financial difficulty” and therefore not eligible for bankruptcy protection. Talc ovarian cancer risk. LTL filed a second bankruptcy in just two hours following the decision to dismiss, arguing that its second attempt was different as there was less money available and had more support for a settlement.

New Mexico and Mississippi said in their motion to dismiss that LTL’s renewed bankruptcy violates state law enforcement authorities by trying to unilaterally cap the liability of the company for state consumer protection actions.

Talc Ovarian Cancer Risk

LTL’s filings for the new year also contained more details on how the company would assess and pay for cancer claims should the bankruptcy plan be approved.

The highest payments under the settlement would be $500,000 for patients diagnosed with mesothelioma terminal prior to age 45. Talc ovarian cancer risk. The second payment would be $260,000 for people diagnosed with ovarian cancer that is terminal before age 45.

The proposed settlement provides discounts based on the nature and severity of the cancer, the person’s years of age, their history of talc use and other factors. Talc ovarian cancer risk. For instance an individual who was using talc products weekly, had the family history of ovarian cancer and was diagnosed an ovarian cancer stage II when she was 55 might qualify to receive a payout of $21,125 under the program.

Judge gives order to J&J and talc opponents to engage in settlement talks.

Following another hearing in Johnson and Johnson’s efforts to utilize a Texas Two-Step bankruptcy strategy for talc litigation, federal bankruptcy Judge Michael Kaplan has ordered the company and those opposed to the plan to hold negotiations to settle the matter, Bloomberg reports.

With its second bankruptcy attempt for LTL management, a subsidiary founded by J&J to handle the claims company offered a settlement of $8.9 billion. Talc ovarian cancer risk. While a firm representing plaintiffs agree with the deal, another group is opposed to the offer.

This week, the opposition group, known as”the Official Committee of Talc Claimants, urged the bankruptcy court for dismissal of the matter asserting that LTL cannot be regarded as in financial distress.

“The filing is an incredibly legal and ineffective attempt by a handful of law firms to try to block claimants from voting on the resolution plan – a plan that the vast majority of claimants favor,” J&J’s litigation chief Erik Haas, said in an announcement. Talc ovarian cancer risk. “The law firms who filed these filings have interests in finance that are in conflict with, diverge from and are in opposition to the interests which their clientele. We will be submitting a response before the court of appeals.”

Talc ovarian cancer risk. Clay Thompson, a lawyer for MRHFM who includes more than mesothelioma victims who have filed lawsuits against J&J and J&J, has said that J&J’s second bankruptcy attempt failed.

“J&J sends out press releases describing how fantastic the plan is but simultaneously insisting that the details of its plan–including the treatment individuals with illnesses would receive–be kept secret,” Thompson said in the statement. “What is J&J’s plan to keep secret?”

4L 4

Kaplan has directed the parties to develop a new restructuring plan, with the supervision and supervision of mediators.

The court in February of 2022 Kaplan affirmed the ability of J&J’s use of Chapter 11 to hasten a settlement that would release J&J from the tens of thousands of claims regarding its talcum products.

In January of this year a federal appeals court ruled against the ruling, ruling that the company was not able to be considered in “financial difficulty.”

The J&J’s plan to challenge the U.S. Supreme Court was denied in April, J&J filed for its second bankruptcy just two hours after. In response, Kaplan froze the lawsuits for 60 calendar days to decide whether or not to approve an additional bankruptcy.

J&J’s unstoppable profit engine goes out of control after $6.9B cost of litigation involving talc.

With the two Chapter 11 attempts, J&J has bought 19 months during which cases were put in limbo. Talc ovarian cancer risk. The company would like claimants to accept their settlement. J&J requires 75% support for the settlement to be approved.

In addition to the team of talc lawyers that criticized the company’s bankruptcy play, the U.S. Trustee, a branch from the U.S. Department of Justice has also filed an application to dismiss the second bankruptcy case of LTL.

In a recent filing, U.S. Trustee Andrew R. Vara wrote that the doors of bankruptcy courts are “open to honest but unfortunate debtors.” The doors “are not open to any parties who do not have a legitimate bankruptcy purpose or that seek to use the bankruptcy process to delay or hinder their creditors,” Vara continued.

On the other hand, J&J maintains there is no evidence conclusive that its Talc products, which includes its iconic baby powder, can cause cancer. J&J has taken its products off of the market–first on North America in 2020–and the rest of the world this year.

J&J seeks to avoid the expense of going to trial. J&J has won most of the cases decided in court, however some losses have been punitive.
A well-known trial in Missouri produced a $4.7 billion verdict against the drug maker but was later reduced to $2.1 billion after appeals.

Johnson & Johnson faces high-stakes hearing over ‘Texas Two Step’ talc strategy: report
Overall, J&J has lost nine trial involving talc that are being appealed or resolved. Out of 41 trials 32 ended with a win by J&J, a mistrial or verdict for a plaintiff that was reversed after appeal. Talc ovarian cancer risk. Additionally, the company in 2020 moved to settle around 1,000 cases for $100 million, Bloomberg announced at that time.

Talcum Baby Powder Ovarian Cancer Lawsuit – Talc Ovarian Cancer Risk

Our lawyers are handling the baby powder litigation in every state. The lawsuits involving talcum powder for Johnson & Johnson have been going on for a long time. Talc ovarian cancer risk. The lawsuits assert that long-term use of the powder (or “talc”), the active ingredient in products like baby Powder as well as Shower to Shower which can cause ovarian cancer in certain women.

This page offers the J&J talc power litigation update and provides an overview of how the upcoming bankruptcy ruling will impact the final settlement amount in the Ovarian Cancer lawsuits.

Is the deadline for you to make a claim for talcum powder? Many who assume the statute of limitations has passed to sue Johnson & Johnson are wrong. Contact us now at 800-553-8082 or get a no-cost, quick case review online.

Johnson and Johnson Talcum Powder Lawsuit Update 2023 – Talc Ovarian Cancer Risk

June 2, 2023 Update: During the asbestos talc case in California yesterday, some technical issues interrupted the opening statements of the defense attorneys. Talc ovarian cancer risk. Jurors who were watching from home via Zoom but did not hear Johnson and Johnson’s lawyer express skepticism about the 70s science claiming asbestos was present in their product before the opening was abruptly ended.

In the meantime, the plaintiff was able to present its first expert witness Arthur Langer. Langer stated that the presence of additional minerals along with talc is expected. He claimed that his group was notified by J&J in 1971 about the presence of asbestos chrysotile in the talc manufactured by the company, though with lesser than 0.1 percent. He also uncovered more asbestos in 1976.

June 1, 2023 Update: Talc ovarian cancer risk. The first trial since J&J made the decision to split its Talc segment and file for bankruptcy is an important moment within the ongoing litigation story. The trial started yesterday in the poignant trial of a young plaintiff, diagnosed with a rare and aggressive form of mesothelioma last year, which both sides agree is a tragic loss.

Opening statements revealed the sharp differences in the two sides’ narrative. The plaintiff’s attorney took aim at Johnson & Johnson, alleging the use of deceptive strategies in its research practices as well as throughout the litigation process. The attorney claims that, according to, the company attempted to manipulate asbestos’ definition, in spite of internal documents dating from the year 1978 and 1994 indicating that fibers discovered in the tissue of the plaintiff are included.

Johnson &J’s tangled $8.9 billion settlement is hanging in the balance with the course of this trial. Despite the unique nature of this mesothelioma-related case and the unique issues it faces compared to other lawsuits involving talcum powder ruling in favor of the plaintiff could cause the company with a major setback in its hopes for broad acceptance of the settlement they have proposed among plaintiffs.

May 31st, 2023 Update: Johnson and Johnson’s bankrupt talc division was able to defend its Second Chapter 11 filing in the in the face of challenges from talc injury claimants. In an appeal to the New Jersey bankruptcy court, J&J’s subsidiary claimed that the filing was vastly different from the first filing. It emphasized the unprecedented commitment of $8.9 billion to J&J, the largest settlement ever in any bankruptcy case that involves mass tort. Talc ovarian cancer risk. Not mentioned: how this amount indicates that it is an equitable settlement. J&J also claimed that it received support from numerous plaintiffs’ law firms representing over the 60,000 plaintiffs. It is difficult to confirm however it is likely to be incorrect.

May 24 2023 Update: In the wake of Johnson &J Johnson’s bankruptcy filing, the first trial on the cosmetic talc products it claims to containing asbestos is set to begin jury selection on Monday, California at Alameda County Superior Court, which is a well-known court for plaintiffs. The plaintiff claims his mesothelioma resulted from asbestos exposure in J&J’s product which that the company is denying. The trial also involves six retailers who are accused of selling talc-containing products.

May 22nd, 2023 Update: Lawyers involved in the 2nd J&J talc bankruptcy are battling over who should be appointed to the role of a the future claims representative, which is vitally critical to resolving talc claims. Talc ovarian cancer risk. Randi Ellis, a lawyer who is frequently involved in MDLs across the country was appointed the claims representative during the first bankruptcy. J&J’s defense attorneys want Ellis to be appointed to that role in the future, however lawyers representing the plaintiffs in talc are arguing because Ellis has conflicts of interest that would prevent her from being appointed to that post once more. The conflict stems from the reality that Ellis was believed to have been involved in the drafting of the highly contesting second bankruptcy, which raises doubts regarding her capacity to remain neutral. In reality, the bankruptcy will get dismissed anyway.

May 17, 2023 Update The fake company J&J made up to settle the talc litigation bankruptcy told a New Jersey bankruptcy court that they have designated $400 million as a settlement for claims made by states accusing the company of deceptive advertising regarding its talc products. Talc ovarian cancer risk. So that makes it an $8.5 billion settlement for cancer sufferers. It is hard to imagine the scenario in which J&J could push the baby powder settlements in these figures. While J&J’s proposed $8.5 billion offer might seem like a lot at first, it does not appear appealing when you look at the numbers. This settlement offer based on our estimates – will not offer victims anything more than an average settlement $100,000 per instance. This isn’t enough.

May 15th, 2023, Update J&J may be in the middle of a lawsuit from an advocacy group representing cancer patients. Talc ovarian cancer risk. The group claims that J&J intentionally withdrew an $61.5 billion fund-raising agreement together with its parent company, LTL Management LLC, in order to create a false sense of financial distress and to validate the company’s Chapter 11 bankruptcy filing. The group asserts this action amounts to a fraudulent transfer of the rights of compensation for victims. They intend to investigate J&J’s actions in the wake of the dismissal of LTL’s first bankruptcy case.

May 10, 2023 Update: Next week this week, it is expected that the U.S. Bankruptcy Court in New Jersey will hear oral arguments on a petition to dismiss the second bankruptcy filing of J&J subsidiary LTL Management. In the meantime, this bankruptcy court has issued an Order requiring both sides to participate in a new settlement mediation in the hope that it will be possible to reach a global settlement agreement brokered.

May 5 2023 Update: Talc producer Whittaker, Clark & Daniels filed for Chapter 11 bankruptcy due to many lawsuits claiming that its talc products caused cancer from asbestos exposure. Talc ovarian cancer risk. Over 2,700 individuals have sued the company and the company was spending $1 million a month to defend its legal position. The company’s most recent $29 million settlement in South Carolina forced it to pursue bankruptcy protection, and arguing for a fair distribution of assets between talc claimants rather than being taken by the receiver. Other suppliers of talc have filed for bankruptcy due to legal proceedings.

May 4, 2023 Update: U.S. bankruptcy judge Michael Kaplan has directed Johnson & Johnson to resume talks with lawyers who have rejected the proposed $8.9 billion deal. The court in Trenton, New Jersey yesterday the parties appeared before a judge to discuss next steps for their second bankruptcy matter and Judge Kaplan was pushing for more settlement discussions.

This is the answer to resolve these claims for J&J. A baby powder settlement can be achieved. Talc ovarian cancer risk. But it’ll need more money – more billions of dollars of Johnson & Johnson.

Lawyers are divided on whether or not to agree with the proposal and not every client sees the situation the same way their lawyer sees it. The second bankruptcy case is expected to fail with Judge Kaplan has set a date for a hearing in June to determine if she will close the case for the third time.

May 3, 2023 Update A group of cancer patients who have sued Johnson & Johnson (J&J) requested that J&J’s Third Circuit halt the bankruptcy filed by J&J subsidiary LTL Management, claiming it is a bid to stop litigation regarding talc-related products. The group representing claimants for talc submitted a motion on Tuesday asking that the Third Circuit to consider their case and then send it back before a court of lower jurisdiction with instructions for dismissing the bankruptcy. Talc ovarian cancer risk. The committee also requested that the stopped tort litigation against J&J be allowed to proceed.
LTL applied for Chapter 11 protection once again following its bankruptcy filing that was rejected in the Third Circuit earlier this year with an $8.9 billion payment. The committee says that the recent ruling which allowed LTL’s second Chapter 11 to continue, and also stopping trials against J&J, warrants the immediate Third Circuit review. The US Trustee also requested that be the New Jersey bankruptcy court dismiss the LTL bankruptcy case. J&J’s vice president for global litigation Erik Haas, was quoted by Bloomberg as saying that J&J intends to file a statement in the appeals court saying that the filing is a “desperate and legally inadequate plan” by a few of law firms who have conflicting financial interests.
May 1 2023 Update: One common question that people ask is how plaintiffs and their lawyers turn on $8.9 billion. Of course, that’s quite a sum. But there are a lot of victims. Talc ovarian cancer risk. They are a great claims for plaintiffs. We were reminded recently when two talc cases led to huge verdicts for plaintiffs. In February the mesothelioma case involving talcum powder trial in Oregon resulted in a verdict in the amount of $18.1 million. In the same month, a different mesothelioma-related talc case went to hearing at South Carolina and resulted in a verdict of $29million in favor of plaintiff. In both instances, the defendant was Whittaker, Clark & Daniels Inc., one of the largest producers of talc in the U.S.
April 30th 2023 Update: In the year 2023, when J&J initially attempted to pull the litigation over talcum powder into bankruptcy, it was met with an offer to reserve $2 billion to settle the case. The sum was ridiculously low. None of the talc plaintiffs believed in it. This time around, however, J&J has increased the offer to $8.9 if the talc plaintiffs agree to a bankruptcy settlement and also has the backing of a significant segment of the talc plaintiffs as well as their lawyers. Talc ovarian cancer risk. However, 75% of plaintiffs in the talc category, which is needed for approval of the bankruptcy plan is not an easy task due to the sheer number of lawyers with massive inventories of baby powder-related lawsuits, opposed against the proposed settlement.

What is the solution to this impasse? More billions.
April 25, 2023 update: Talc plaintiffs have requested a judge to dismiss the Chapter 11 case filed by LTL Management LLC, a absurdly-made-up Johnson & Johnson subsidiary, saying the company is not financially distressed. LTL applied for Chapter 11 to settle tens of thousands of claims that J&J’s baby products caused cancer. Talc ovarian cancer risk. The 3rd Circuit dismissed its first Chapter 11 case in January and said that the company wasn’t eligible for bankruptcy relief because it had not demonstrated financial distress.

The claimants contend that the second Chapter 11 case is an fraud on the bankruptcy system and that it’s being pursued in bad faith. J&J states that the bankruptcy settlement has “significant backing” from firms representing around 60,000 claimants. It’s fair to say that lawyers representing plaintiffs and victims ‘ lawyers are not united over their disagreement over the $8.9 billion deal.

April 21st, 2023 Update: A bankruptcy judge has ruled in favor of Johnson & Johnson must face new lawsuits alleging that the firm sold a baby powder that contained a chemical that causes cancer. Although the trials for the lawsuits involving talc are delayed for at least 60 days but new lawsuits can be filed and lawyers will begin preparing their cases. Talc ovarian cancer risk. Judges expressed doubt about J&J’s ridiculous effort to revive its strategy by filing a second bankruptcy trial.

April 13th, 2023 Update: most important update is about the $8.9 billion over 25 year period settlement offered. Lawyers representing cancer patients involved in MDL class action MDL group action pledged to challenge the settlement Talc claimants. Why? They argue that it’s too little money for the 70,000 victims who have cancer. Talc ovarian cancer risk. These lawyers believe that J&J should negotiate a larger settlement or litigate individual claims if the most recent bankruptcy is dismissed.

But there is another set of lawyers who are not part of the top leadership in the class action. These lawyers have amassed hundreds of thousands of cases. The group is seeking to settle today for what many argue is less than the victims deserve. Their argument is two-fold. They argue that the settlement – about 100 million dollars on average per plaintiff is fair.

It’s a difficult argument to argue. But their second argument has more teeth: victims can now not wait and they want their money today.

April 12 2023 Update: Some people are wondering if J&J could file for bankruptcy once more. The answer is complex and confusing. But let’s try to explain it simply.
Johnson & Johnson asserts that bankruptcy is the only option to resolve both current and future talc litigations in a definitive manner. Also, it believes that it will be less expensive should there be a bankruptcy component that applies pressure to settle. Talc ovarian cancer risk. In a quest to cover 400 years of American history, the firm asserts that bankruptcy benefits everyone by dispersing settlements more equally and efficiently than trial courts, in which some litigants receive substantial award while others do not.

The gist in the 3rd Circuit decision was this is not a case – an enterprise that is profitable, forming an entity to assume the legal burden and declare bankruptcy – Congress had in mind when it came to drafting the Bankruptcy Code. It also clarified that the entity was financially crisis due to the fact that J&J offered unlimited financing.
Thus, J&J took advantage of the funding unlimited part of the contract and didn’t make any promises that it would provide unlimited funds for the litigation. The company says that its modified financing arrangements with its subsidiary address the concerns of the appeals court while providing funds for claims. In the hope that offering victims lesser money could solve the overarching problem.

Attorneys representing cancer patients who oppose the agreement counter the agreement with what is the legal argument. Talc ovarian cancer risk. They counter with legal absurdity: J&J fraudulently transferred $50 billion of assets from LTL Management to circumvent the appeals court’s decision. Hyperbole did not go unnoticed attorneys representing the victims claim it the most significant “fraudulent transaction of assets in United States history.”

Despite the legal jargon, J&J does not really believe that this bankruptcy will last. However, it’s a means of trying to push this $8.9 billion settlement, and to keep pressure on plaintiffs.

April 10, 2023 update: Bloomberg has an interesting article about a new law within New Jersey that is shedding new light on litigation funding in the Class action suit. Litigation funders Virage Capital Management and TRGP Capital invested in hundreds of claims from Johnson & Johnson (J&J) regarding talc products, in exchange in exchange for a portion of wins. J&J has now offered an offer of $8.9 billion to settle any lawsuits.

The involvement of funders is public knowledge because of the New Jersey court rule requiring the disclosure of certain information about outside funding backers. The rules aim to address the growing calls for regulation of the litigation funders. J&J has more than 60,000 claims when you combine state and federal baby powder lawsuits. Third-party funding in mass tort claims has its pros and cons. But there is no question that we are seeing how third-party funding can level the playing field between individual and large corporations in court.

April 4 2023 Update: It is enjoyable to see the worm turning in this lawsuit. J&J took another hit this week, when it was found that the Third Circuit denied J&J’s request to maintain the automatic stay during the time that J&J appeals a bankruptcy decision in the U.S. Supreme Court. It has stopped hundreds of cases involving talcum powder and prevented new lawsuits from getting filed ever since J&J launched the controversial attempt to spin the talc debts off into a bankrupt subsidiary over one year in the past. Talc ovarian cancer risk. After it was decided that the 3rd Circuit ruled that this bankruptcy was not valid just a few months ago the stay was removed. J&J wanted to see it continued pending an appeal to the SCOTUS appeal. However, the answer was no.
April 1st, 2023 Update Johnson & Johnson announced it will appeal its 3rd Circuit bankruptcy loss to the U.S. Supreme Court last week. The chance of the Supreme Court is willing even to consider the appeal? Low.
March 16 2023 Update: with the bankruptcy stay having been officially lifted, the first new cases have been filed and transferred into the class action involving talcum powder MDL in over one year. Seven new talc cases were joined to the MDL during the month of March which brings the total number of pending cases up to 37,522.

February 25, 2023 Update: A Congressmen from Tennessee is now demanding that be the U.S. Government Accountability Office (GAO) initiate an investigation into the amount J&J talc products have cost the government in the years.
A recent email to the GAO, Rep. Steven Cohen (D-Ten.) accused J&J of not recognizing the risks of its talc-based products for long while tax dollars spent on treating people who suffered injuries from exposure to the chemicals. The demand comes just weeks after J&J’s loss to the 3rd Circuit Court of Appeals.

Talc ovarian cancer risk. J&J needs to start making reasonable settlements to victims to the process of putting all this behind. It is a stain on one of the top companies.

February 14 2023 Update: In the hearing held today at the hearing in New Jersey, U.S. Bankruptcy Judge Michael Kaplan announced his intention in light of the 3rd U.S. Circuit Court of Appeals ruling to dismiss the bankruptcy case.